This study aimed to evaluate the correlation of HPV infection and the expression of p53 and p16 with clinicopathologic factors, and whether they are ESCC prognostic factors for cancer progression (survival). The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.